메뉴 건너뛰기
Journal of Cardiac Failure
Volumn 19, Issue 8, 2013, Pages 540-541
Expanding the scope of the "polypill" to heart failure
Author keywords

[No Author keywords available]
Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST;
EID: 84881193615     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.05.017     Document Type: Article
Times cited : (5)
References (9)
  • 1
    • 74849098087 scopus 로고    scopus 로고
    • Clinical practice. Systolic heart failure
    • J.J. McMurray Clinical practice. Systolic heart failure N Engl J Med 362 2010 228 238
    • (2010) N Engl J Med , vol.362 , pp. 228-238
    • McMurray, J.J.1
  • 3
    • 77956612624 scopus 로고    scopus 로고
    • Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study
    • K. Swedberg, M. Komajda, M. Bohm, J.S. Borer, I. Ford, and A. Dubost-Brama Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
    • (2010) Lancet , vol.376 , pp. 875-885
    • Swedberg, K.1    Komajda, M.2    Bohm, M.3    Borer, J.S.4    Ford, I.5    Dubost-Brama, A.6
  • 4
    • 79951699237 scopus 로고    scopus 로고
    • Thirty-day readmission rates for Medicare beneficiaries by race and site of care
    • K.E. Joynt, E.J. Orav, and A.K. Jha Thirty-day readmission rates for Medicare beneficiaries by race and site of care JAMA 305 2011 675 681
    • (2011) JAMA , vol.305 , pp. 675-681
    • Joynt, K.E.1    Orav, E.J.2    Jha, A.K.3
  • 5
    • 84875444327 scopus 로고    scopus 로고
    • Incremental cost-effectiveness of guideline-directed medical therapies for heart failure
    • G. Banka, P.A. Heidenreich, and G.C. Fonarow Incremental cost-effectiveness of guideline-directed medical therapies for heart failure J Am Coll Cardiol 61 2013 1440 1446
    • (2013) J Am Coll Cardiol , vol.61 , pp. 1440-1446
    • Banka, G.1    Heidenreich, P.A.2    Fonarow, G.C.3
  • 6
    • 84873350548 scopus 로고    scopus 로고
    • Benefits of beta blockers in patients with heart failure and reduced ejection fraction: Network meta-analysis
    • S. Chatterjee, G. Biondi-Zoccai, A. Abbate, F. d'Ascenzo, D. Castagno, and B. van Tassell Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis BMJ 346 2013 f55
    • (2013) BMJ , vol.346 , pp. 55
    • Chatterjee, S.1    Biondi-Zoccai, G.2    Abbate, A.3    D'Ascenzo, F.4    Castagno, D.5    Van Tassell, B.6
  • 7
    • 84876337781 scopus 로고    scopus 로고
    • Combination therapy to prevent cardiovascular disease: Slow progress
    • R. Smith, T. McCready, and S. Yusuf Combination therapy to prevent cardiovascular disease: slow progress JAMA 309 2013 1595 1596
    • (2013) JAMA , vol.309 , pp. 1595-1596
    • Smith, R.1    McCready, T.2    Yusuf, S.3
  • 8
    • 84869840351 scopus 로고    scopus 로고
    • Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction
    • A.F. Hernandez, X. Mi, B.G. Hammill, S.C. Hammill, P.A. Heidenreich, and F.A. Masoudi Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction JAMA 308 2012 2097 2107
    • (2012) JAMA , vol.308 , pp. 2097-2107
    • Hernandez, A.F.1    Mi, X.2    Hammill, B.G.3    Hammill, S.C.4    Heidenreich, P.A.5    Masoudi, F.A.6
  • 9
    • 84877951150 scopus 로고    scopus 로고
    • Medication nonadherence: A diagnosable and treatable medical condition
    • Z.A. Marcum, M.A. Sevick, and S.M. Handler Medication nonadherence: a diagnosable and treatable medical condition JAMA 309 2013 2105 2106
    • (2013) JAMA , vol.309 , pp. 2105-2106
    • Marcum, Z.A.1    Sevick, M.A.2    Handler, S.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.